Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports
DALLAS, November 1, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Research Report in its store.
Browse the complete Report on: http://www.reportsnreports.com/Reports/37204-peripheral-arterial-disease-pad- pipeline-assessment-and-marke.html
Browse All Manufacturing & Construction Reports: http://www.reportsnreports.com/market-research/pharmaceuticals/
Browse All GlobalData Research Reports at http://www.reportsnreports.com/publishers/globaldata/
GlobalData, the industry analysis specialist, has released its new report, "Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global PAD market. The report identifies the key trends shaping and driving the global PAD market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PAD sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
The global PAD therapeutics market accounted for approximately $606m in 2009. In 2001, the market was valued at $405m and it grew at an approximate CAGR of 5.2% between 2001 and 2009. The global PAD therapeutics market is expected to reach $1 billion by 2017 growing at a CAGR of 6.5% between 2009 and 2017. The primary factor contributing to the increase in growth over the forecast period is the increase in disease incidence and the launch of new first-in-class drugs. Presently the therapeutic regimen for PAD consists of antiplatelet agents such as clopidogrel (Plavix) and ticlopidine (Ticlid). Blood thinners such as pentoxifyline (Trental) and Cilostazol (Pletal) are also prescribed. Like most cardiovascular complications, aspirin is used as a complementary drug in combination with the above mentioned drugs.
Scope
The report provides information on the key drivers and challenges of the PAD market. Its scope includes: - Annualized global PAD market revenues data from 2001 to 2009, forecast for eight years to 2017. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as of gene therapy, stem cell therapy, platelet aggregation inhibitor, Hydroxymethylglutaryl-CoA reductase inhibitor, monoclonal antibody, micro RNA, protein kinase modulator, Y2 agonist, and PPAR (Peroxisome Proliferator Activated Receptor) agonist. - Analysis of the current and future competition in the global PAD market. Key market players covered are Sanofi Aventis, Indigo pharmaceuticals, BioMarin Pharmaceutical, and AnGes MG Inc. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PAD therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to: - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global PAD market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global PAD market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What's the next big thing in the global PAD market landscape? - Identify, understand and capitalize.
Browse All Specific Markets: http://www.reportsnreports.com/tagIndex.aspx
Browse All Latest Reports: http://www.reportsnreports.com/LatestReport.aspx
Related Reports
Peripheral Arterial Disease (PAD) - Drug Pipeline Analysis and Market Forecasts to 2016 ( http://www.reportsnreports.com/reports/16053-peripheral-arterial-disease-pad- drug-pipeline-analysis-and-ma.html)
Peripheral Arterial Disease Therapy Area Pipeline Report ( http://www.reportsnreports.com/reports/32464-peripheral-arterial-disease-ther apy-area-pipeline-report.html)
Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017 (http://www.reportsnreports.com/reports/36584-influenza-vaccines-pipeline-ass essment-and-market-forecasts-to-.html)
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017 (http://www.reportsnreports.com/reports/36585-head-and-neck-cancer-pipeline-a ssessment-and-market-forecast-to.html)
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017 (http://www.reportsnreports.com/reports/37160-rheumatoid-arthritis-pipeline-a ssessment-and-market-forecasts-t.html)
Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017 ( http://www.reportsnreports.com/reports/37161-systemic-lupus-erythematosus-pip eline-assessment-and-market-for.html)
Anemia - Pipeline Assessment and Market Forecasts to 2017 ( http://www.reportsnreports.com/reports/37162-anemia-pipeline-assessment-and-m arket-forecasts-to-2017.html)
Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017 ( http://www.reportsnreports.com/reports/37205-growth-hormone-deficiency-ghd-pi peline-assessment-and-market-.html)
Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017 (http://www.reportsnreports.com/reports/25702-type-1-diabetes-drug-pipeline-a ssessment-and-market-forecasts-t.html)
Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 ( http://www.reportsnreports.com/reports/27388-hormone-replacement-therapy-in-m enopause-pipeline-assessment-an.html)
(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://www.reportsnreports.com/
SOURCE MarketsandMarkets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article